Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatment
Not Applicable
- Conditions
- Glucocorticoid induced osteoporosis in patients with IgA nephropathy
- Registration Number
- JPRN-UMIN000002474
- Lead Sponsor
- Osaka University Hospital Department of nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1, women who hope for future pregnancy 2, patients who already have had osteopenia or osteoporosis 3, patients with chronic kidney disease stage 3-5 4, postmenopausal women 5, patients with any prior history of glucocorticoid therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in 3-dimensional trabecular bone structure at 6-month after the start of intervention
- Secondary Outcome Measures
Name Time Method Changes in bone turnover markers and bone mineral density